Vaxart, Inc. (46)
Browse by Contract Category
Contracts
-
Pre-Challenge Study Services Agreement dated June 29, 2022, between the Company and hVIVO Services Limited
(Filed With SEC on August 8, 2022)
-
2022 Employee Stock Purchase Plan
(Filed With SEC on August 5, 2022)
-
2019 Equity Incentive Plan
(Filed With SEC on August 5, 2022)
-
Offer letter, dated January 18, 2022, by and between the Company and Edward Berg
(Filed With SEC on February 24, 2022)
-
Lease Agreement, dated September 17, 2021, by and between Vaxart, Inc. and Britannia Pointe Grand Limited Partnership
(Filed With SEC on September 21, 2021)
-
CONSULTING SERVICES AGREEMENT
(Filed With SEC on May 11, 2022)
-
CONFIDENTIAL CONSULTING AGREEMENT
(Filed With SEC on May 11, 2022)
-
Non-Employee Director Compensation Program, effective as of April 1, 2022
(Filed With SEC on May 9, 2022)
-
Asset Purchase Agreement, dated November 24, 2021, by and between Vaxart, Inc. and Kindred Biosciences, Inc
(Filed With SEC on February 24, 2022)
-
Description of Securities of the Registrant
(Filed With SEC on February 24, 2022)
-
Offer Letter, dated August 16, 2021, by and between the Company and James Cummings MD
(Filed With SEC on November 4, 2021)
-
Second Amendment to Lease Agreement, dated September 17, 2021, by and between Vaxart, Inc. and Healthpeak Properties, Inc
(Filed With SEC on September 21, 2021)
-
Controlled Equity OfferingSM Sales Agreement
(Filed With SEC on September 16, 2021)
-
Vaxart, Inc. 2019 Equity Incentive Plan (as amended on April 28, 2021)
(Filed With SEC on June 21, 2021)
-
Sublease Agreement dated November 16, 2020, by and between Vaxart, Inc. and Vera Therapeutics, Inc
(Filed With SEC on February 25, 2021)
-
Description of Securities of the Registrant
(Filed With SEC on February 25, 2021)
-
Statement of Work 004, dated September 11, 2020, under the Master Services Agreement, dated April 17, 2020, by and between Vaxart, Inc. and Kindred Biosciences, Inc
(Filed With SEC on November 12, 2020)
-
Statement of Work 003, dated September 11, 2020, under the Master Services Agreement, dated April 17, 2020, by and between Vaxart, Inc. and Kindred Biosciences, Inc
(Filed With SEC on November 12, 2020)
-
Master Services Agreement, dated April 17, 2020, by and between Vaxart, Inc. and Kindred Biosciences, Inc
(Filed With SEC on November 12, 2020)
-
OPEN MARKET SALE AGREEMENTSM
(Filed With SEC on October 14, 2020)
-
Separation Agreement, dated June 14, 2020, between Vaxart, Inc. and Wouter W. Latour, M.D
(Filed With SEC on June 15, 2020)
-
Letter Agreement, dated June 14, 2020, between Vaxart, Inc. and Andrei Floroiu
(Filed With SEC on June 15, 2020)
-
Letter dated December 27, 2018, from the Company to Margaret Echerd
(Filed With SEC on May 12, 2020)
-
Offer Letter, dated March 26, 2018, by and between the Company and Margaret Echerd
(Filed With SEC on May 12, 2020)
-
Offer Letter, dated May 1, 2006, by and between the Company and Dr. Sean Tucker
(Filed With SEC on May 12, 2020)
-
Description of Securities of the Registrant
(Filed With SEC on March 19, 2020)
-
Form of Securities Purchase Agreement, dated February 27, 2020, among the Company and the Purchasers named therein
(Filed With SEC on March 2, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on March 2, 2020)
-
Form of Warrant
(Filed With SEC on March 2, 2020)
-
Form of Representative Warrant
(Filed With SEC on September 24, 2019)
-
Underwriting Agreement
(Filed With SEC on September 24, 2019)
-
Manufacturing Services Agreement dated July 17, 2019, by and between Vaxart, Inc. and Lonza Houston, Inc
(Filed With SEC on September 24, 2019)
-
First Amendment to Lease Agreement dated September 17, 2019, by and between Vaxart, Inc. and HCP, Inc
(Filed With SEC on September 19, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on September 11, 2019)
-
Form of Common Warrant
(Filed With SEC on September 11, 2019)
-
Form of Representative Warrant
(Filed With SEC on September 11, 2019)
-
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan
(Filed With SEC on April 24, 2019)
-
Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the 2019 Equity Incentive Plan
(Filed With SEC on April 24, 2019)
-
2019 Equity Incentive Plan
(Filed With SEC on April 24, 2019)
-
Form of Representative Warrant
(Filed With SEC on April 8, 2019)
-
Form of Common Warrant
(Filed With SEC on April 8, 2019)
-
Underwriting Agreement
(Filed With SEC on April 8, 2019)
-
Form of Placement Warrants
(Filed With SEC on March 20, 2019)
-
Engagement Letter, dated as of January 25, 2019, by and between Vaxart, Inc. and H.C. Wainwright & Co., LLC., as amended
(Filed With SEC on March 20, 2019)
-
Form of Securities Purchase Agreement, dated as of March 19, 2019, by and among Vaxart, Inc. and the Purchasers named therein
(Filed With SEC on March 20, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 6, 2019)
